Cargando…

Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment

Introduction: There is evidence that sample treatment of blood-based biosamples may affect integral signals in nuclear magnetic resonance-based metabolomics. The presence of macromolecules in plasma/serum samples makes investigating low-molecular-weight metabolites challenging. It is particularly re...

Descripción completa

Detalles Bibliográficos
Autores principales: Madrid-Gambin, Francisco, Oller, Sergio, Marco, Santiago, Pozo, Óscar J., Andres-Lacueva, Cristina, Llorach, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273206/
https://www.ncbi.nlm.nih.gov/pubmed/37333016
http://dx.doi.org/10.3389/fmolb.2023.1125582
_version_ 1785059646761861120
author Madrid-Gambin, Francisco
Oller, Sergio
Marco, Santiago
Pozo, Óscar J.
Andres-Lacueva, Cristina
Llorach, Rafael
author_facet Madrid-Gambin, Francisco
Oller, Sergio
Marco, Santiago
Pozo, Óscar J.
Andres-Lacueva, Cristina
Llorach, Rafael
author_sort Madrid-Gambin, Francisco
collection PubMed
description Introduction: There is evidence that sample treatment of blood-based biosamples may affect integral signals in nuclear magnetic resonance-based metabolomics. The presence of macromolecules in plasma/serum samples makes investigating low-molecular-weight metabolites challenging. It is particularly relevant in the targeted approach, in which absolute concentrations of selected metabolites are often quantified based on the area of integral signals. Since there are a few treatments of plasma/serum samples for quantitative analysis without a universally accepted method, this topic remains of interest for future research. Methods: In this work, targeted metabolomic profiling of 43 metabolites was performed on pooled plasma to compare four methodologies consisting of Carr-Purcell-Meiboom-Gill (CPMG) editing, ultrafiltration, protein precipitation with methanol, and glycerophospholipid solid-phase extraction (g-SPE) for phospholipid removal; prior to NMR metabolomics analysis. The effect of the sample treatments on the metabolite concentrations was evaluated using a permutation test of multiclass and pairwise Fisher scores. Results: Results showed that methanol precipitation and ultrafiltration had a higher number of metabolites with coefficient of variation (CV) values above 20%. G-SPE and CPMG editing demonstrated better precision for most of the metabolites analyzed. However, differential quantification performance between procedures were metabolite-dependent. For example, pairwise comparisons showed that methanol precipitation and CPMG editing were suitable for quantifying citrate, while g-SPE showed better results for 2-hydroxybutyrate and tryptophan. Discussion: There are alterations in the absolute concentration of various metabolites that are dependent on the procedure. Considering these alterations is essential before proceeding with the quantification of treatment-sensitive metabolites in biological samples for improving biomarker discovery and biological interpretations. The study demonstrated that g-SPE and CPMG editing are effective methods for removing proteins and phospholipids from plasma samples for quantitative NMR analysis of metabolites. However, careful consideration should be given to the specific metabolites of interest and their susceptibility to the sample treatment procedures. These findings contribute to the development of optimized sample preparation protocols for metabolomics studies using NMR spectroscopy.
format Online
Article
Text
id pubmed-10273206
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102732062023-06-17 Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment Madrid-Gambin, Francisco Oller, Sergio Marco, Santiago Pozo, Óscar J. Andres-Lacueva, Cristina Llorach, Rafael Front Mol Biosci Molecular Biosciences Introduction: There is evidence that sample treatment of blood-based biosamples may affect integral signals in nuclear magnetic resonance-based metabolomics. The presence of macromolecules in plasma/serum samples makes investigating low-molecular-weight metabolites challenging. It is particularly relevant in the targeted approach, in which absolute concentrations of selected metabolites are often quantified based on the area of integral signals. Since there are a few treatments of plasma/serum samples for quantitative analysis without a universally accepted method, this topic remains of interest for future research. Methods: In this work, targeted metabolomic profiling of 43 metabolites was performed on pooled plasma to compare four methodologies consisting of Carr-Purcell-Meiboom-Gill (CPMG) editing, ultrafiltration, protein precipitation with methanol, and glycerophospholipid solid-phase extraction (g-SPE) for phospholipid removal; prior to NMR metabolomics analysis. The effect of the sample treatments on the metabolite concentrations was evaluated using a permutation test of multiclass and pairwise Fisher scores. Results: Results showed that methanol precipitation and ultrafiltration had a higher number of metabolites with coefficient of variation (CV) values above 20%. G-SPE and CPMG editing demonstrated better precision for most of the metabolites analyzed. However, differential quantification performance between procedures were metabolite-dependent. For example, pairwise comparisons showed that methanol precipitation and CPMG editing were suitable for quantifying citrate, while g-SPE showed better results for 2-hydroxybutyrate and tryptophan. Discussion: There are alterations in the absolute concentration of various metabolites that are dependent on the procedure. Considering these alterations is essential before proceeding with the quantification of treatment-sensitive metabolites in biological samples for improving biomarker discovery and biological interpretations. The study demonstrated that g-SPE and CPMG editing are effective methods for removing proteins and phospholipids from plasma samples for quantitative NMR analysis of metabolites. However, careful consideration should be given to the specific metabolites of interest and their susceptibility to the sample treatment procedures. These findings contribute to the development of optimized sample preparation protocols for metabolomics studies using NMR spectroscopy. Frontiers Media S.A. 2023-06-02 /pmc/articles/PMC10273206/ /pubmed/37333016 http://dx.doi.org/10.3389/fmolb.2023.1125582 Text en Copyright © 2023 Madrid-Gambin, Oller, Marco, Pozo, Andres-Lacueva and Llorach. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Madrid-Gambin, Francisco
Oller, Sergio
Marco, Santiago
Pozo, Óscar J.
Andres-Lacueva, Cristina
Llorach, Rafael
Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment
title Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment
title_full Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment
title_fullStr Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment
title_full_unstemmed Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment
title_short Quantitative plasma profiling by (1)H NMR-based metabolomics: impact of sample treatment
title_sort quantitative plasma profiling by (1)h nmr-based metabolomics: impact of sample treatment
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273206/
https://www.ncbi.nlm.nih.gov/pubmed/37333016
http://dx.doi.org/10.3389/fmolb.2023.1125582
work_keys_str_mv AT madridgambinfrancisco quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment
AT ollersergio quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment
AT marcosantiago quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment
AT pozooscarj quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment
AT andreslacuevacristina quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment
AT llorachrafael quantitativeplasmaprofilingby1hnmrbasedmetabolomicsimpactofsampletreatment